Acura Pharmaceuticals (ACUR) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Abuse Deterrent Pharma, LLC, controlled by Mr. Schutte, has provided a $250,000 loan to a company, increasing its total debt to $5,169,279, due by March 31, 2024, with a 5.25% interest rate, escalating to 7.5% upon default. The funds are earmarked for operational costs through mid-March, but the company warns of potential operational scale-back or bankruptcy if additional financing is not secured, posing a risk of complete shareholder value loss. AD Pharma currently owns around 65% of the company’s common stock, excluding warrants for an additional 10 million shares.
For further insights into ACUR stock, check out TipRanks’ Stock Analysis page.
